Tocilizumab in Severe COVID-19 Disease: Does Timing Matters?

被引：0
|
作者：
Cherrez-Ojeda, I. [1 ]
Vanegas, E. [2 ]
Felix, M. [2 ]
Tovar, M. [3 ]
Bravo, P. [3 ]
Pena, J. [3 ]
Jauregui, J. [3 ]
Silva, D. [3 ]
Bolona, E. [3 ]
机构：
[1] Respiralab, Guayaquil, Ecuador
[2] Univ Espiritu Santo, Samborondon, Ecuador
[3] Clin Guayaquil, Guayaquil, Ecuador
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2653
引用
收藏
页数：2
相关论文
共 50 条
  • [41] BARICITINIB VERSUS TOCILIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19
    Lewis-Wolfson, Temeka
    Joyner, Kayla
    Reid, Nancy
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 191 - 191
  • [42] Adverse Effects of Tocilizumab Versus Baricitinib in Severe COVID-19
    Leaf, David E.
    Gordon, Anthony C.
    Lawler, Patrick R.
    CRITICAL CARE MEDICINE, 2023, 51 (09) : E184 - E185
  • [43] Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19
    Nakamura, Hideta
    Miyagi, Kazuya
    Otsuki, Mariko
    Higure, Yuuri
    Nishiyama, Naoya
    Kinjo, Takeshi
    Nakamatsu, Masashi
    Haranaga, Shusaku
    Tateyama, Masao
    Fujita, Jiro
    INTERNAL MEDICINE, 2020, 59 (22) : 2945 - 2949
  • [44] Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study
    Rojas-Marte, G.
    Khalid, M.
    Mukhtar, O.
    Hashmi, A. T.
    Waheed, M. A.
    Ehrlich, S.
    Aslam, A.
    Siddiqui, S.
    Agarwal, C.
    Malyshev, Y.
    Henriquez-Felipe, C.
    Sharma, D.
    Sharma, S.
    Chukwuka, N.
    Rodriguez, D. C.
    Alliu, S.
    Le, J.
    Shani, J.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (08) : 546 - 550
  • [45] Concise Commentary: Does COVID-19 Worsen Severe Pancreaticobiliary Disease?
    Kim, Marina
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (08) : 3019 - 3020
  • [46] Tocilizumab for the treatment of COVID-19
    Fernandez-Ruiz, Mario
    Lopez-Medrano, Francisco
    Aguado, Jose Maria
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 431 - 434
  • [47] Tocilizumab for the treatment of COVID-19
    Flisiak, Robert
    Flisiak-Jackiewicz, Marta
    Rzymski, Piotr
    Zarebska-Michaluk, Dorota
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (08) : 791 - 797
  • [48] Time for tocilizumab in COVID-19?
    Ethan Butler
    Marie Warrer Munch
    Balasubramanian Venkatesh
    Intensive Care Medicine, 2021, 47 : 692 - 694
  • [49] Tocilizumab in Covid-19 Reply
    Stone, John H.
    Horick, Nora K.
    Healy, Brian C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (01): : 87 - 87
  • [50] Tocilizumab therapy and COVID-19
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    JOURNAL OF OSTEOPATHIC MEDICINE, 2021, 121 (11): : 865 - 865
12345